Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981259575> ?p ?o ?g. }
- W1981259575 endingPage "1733" @default.
- W1981259575 startingPage "1730" @default.
- W1981259575 abstract "SummaryBackground: A prolonged treatment with oral anticoagulants has been claimed to reduce the incidence of newly diagnosed cancer in the long-term follow-up of patients with venous thromboembolism. Objectives: In a multicenter prospective study we assessed the incidence of newly diagnosed clinically overt cancer in patients with a first episode of idiopathic venous thromboembolism (VTE) treated with oral anticoagulants for 3 months or 1 year. Patients and methods: Consecutive patients with an idiopathic venous thromboembolism who had completed 3 months of oral anticoagulant therapy without having a recurrence, bleeding or newly diagnosed cancer were randomized to discontinue oral anticoagulant therapy or to continue it for nine additional months. Idiopathic venous thromboembolism was defined as thrombosis occurring in the absence of known cancer, known thrombophilia, or temporary risk factors for venous thromboembolism. All patients were followed up for at least 1 year after randomization. Results: A total of 429 patients, 265 patients with DVT and 164 with PE, were followed up for an average of 43.7 months after randomization. A newly diagnosed cancer occurred in 32 patients (7.5%), 13 (6.2%) of the 210 patients treated for 3 months and 19 (8.7%) of the 219 patients treated for 1 year (RR = 0.71, 95% confidence interval 0.36–1.41). Conclusions: The incidence of newly diagnosed clinically overt cancer is not reduced in patients with idiopathic venous thromboembolism treated with 1-year anticoagulant treatment compared with patients treated for 3 months. Background: A prolonged treatment with oral anticoagulants has been claimed to reduce the incidence of newly diagnosed cancer in the long-term follow-up of patients with venous thromboembolism. Objectives: In a multicenter prospective study we assessed the incidence of newly diagnosed clinically overt cancer in patients with a first episode of idiopathic venous thromboembolism (VTE) treated with oral anticoagulants for 3 months or 1 year. Patients and methods: Consecutive patients with an idiopathic venous thromboembolism who had completed 3 months of oral anticoagulant therapy without having a recurrence, bleeding or newly diagnosed cancer were randomized to discontinue oral anticoagulant therapy or to continue it for nine additional months. Idiopathic venous thromboembolism was defined as thrombosis occurring in the absence of known cancer, known thrombophilia, or temporary risk factors for venous thromboembolism. All patients were followed up for at least 1 year after randomization. Results: A total of 429 patients, 265 patients with DVT and 164 with PE, were followed up for an average of 43.7 months after randomization. A newly diagnosed cancer occurred in 32 patients (7.5%), 13 (6.2%) of the 210 patients treated for 3 months and 19 (8.7%) of the 219 patients treated for 1 year (RR = 0.71, 95% confidence interval 0.36–1.41). Conclusions: The incidence of newly diagnosed clinically overt cancer is not reduced in patients with idiopathic venous thromboembolism treated with 1-year anticoagulant treatment compared with patients treated for 3 months." @default.
- W1981259575 created "2016-06-24" @default.
- W1981259575 creator A5023493052 @default.
- W1981259575 creator A5030954524 @default.
- W1981259575 creator A5040991094 @default.
- W1981259575 creator A5054783539 @default.
- W1981259575 creator A5055442348 @default.
- W1981259575 creator A5055853592 @default.
- W1981259575 creator A5061803251 @default.
- W1981259575 creator A5064108429 @default.
- W1981259575 creator A5064607336 @default.
- W1981259575 creator A5066223854 @default.
- W1981259575 creator A5071441515 @default.
- W1981259575 creator A5081041579 @default.
- W1981259575 creator A5081678850 @default.
- W1981259575 creator A5082376471 @default.
- W1981259575 date "2003-08-01" @default.
- W1981259575 modified "2023-10-10" @default.
- W1981259575 title "Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation" @default.
- W1981259575 cites W1863488026 @default.
- W1981259575 cites W1895600627 @default.
- W1981259575 cites W1967832446 @default.
- W1981259575 cites W1968462114 @default.
- W1981259575 cites W1999668293 @default.
- W1981259575 cites W2002938738 @default.
- W1981259575 cites W2035568195 @default.
- W1981259575 cites W2057586524 @default.
- W1981259575 cites W2105054066 @default.
- W1981259575 cites W2337548499 @default.
- W1981259575 cites W2568332688 @default.
- W1981259575 cites W4324114533 @default.
- W1981259575 doi "https://doi.org/10.1046/j.1538-7836.2003.00293.x" @default.
- W1981259575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12911585" @default.
- W1981259575 hasPublicationYear "2003" @default.
- W1981259575 type Work @default.
- W1981259575 sameAs 1981259575 @default.
- W1981259575 citedByCount "55" @default.
- W1981259575 countsByYear W19812595752012 @default.
- W1981259575 countsByYear W19812595752014 @default.
- W1981259575 countsByYear W19812595752015 @default.
- W1981259575 countsByYear W19812595752016 @default.
- W1981259575 countsByYear W19812595752017 @default.
- W1981259575 countsByYear W19812595752018 @default.
- W1981259575 countsByYear W19812595752019 @default.
- W1981259575 countsByYear W19812595752021 @default.
- W1981259575 countsByYear W19812595752022 @default.
- W1981259575 countsByYear W19812595752023 @default.
- W1981259575 crossrefType "journal-article" @default.
- W1981259575 hasAuthorship W1981259575A5023493052 @default.
- W1981259575 hasAuthorship W1981259575A5030954524 @default.
- W1981259575 hasAuthorship W1981259575A5040991094 @default.
- W1981259575 hasAuthorship W1981259575A5054783539 @default.
- W1981259575 hasAuthorship W1981259575A5055442348 @default.
- W1981259575 hasAuthorship W1981259575A5055853592 @default.
- W1981259575 hasAuthorship W1981259575A5061803251 @default.
- W1981259575 hasAuthorship W1981259575A5064108429 @default.
- W1981259575 hasAuthorship W1981259575A5064607336 @default.
- W1981259575 hasAuthorship W1981259575A5066223854 @default.
- W1981259575 hasAuthorship W1981259575A5071441515 @default.
- W1981259575 hasAuthorship W1981259575A5081041579 @default.
- W1981259575 hasAuthorship W1981259575A5081678850 @default.
- W1981259575 hasAuthorship W1981259575A5082376471 @default.
- W1981259575 hasBestOaLocation W19812595751 @default.
- W1981259575 hasConcept C120665830 @default.
- W1981259575 hasConcept C121332964 @default.
- W1981259575 hasConcept C121608353 @default.
- W1981259575 hasConcept C126322002 @default.
- W1981259575 hasConcept C141071460 @default.
- W1981259575 hasConcept C168563851 @default.
- W1981259575 hasConcept C188816634 @default.
- W1981259575 hasConcept C204243189 @default.
- W1981259575 hasConcept C2780011451 @default.
- W1981259575 hasConcept C2780842393 @default.
- W1981259575 hasConcept C2780868729 @default.
- W1981259575 hasConcept C2991741193 @default.
- W1981259575 hasConcept C61511704 @default.
- W1981259575 hasConcept C71924100 @default.
- W1981259575 hasConceptScore W1981259575C120665830 @default.
- W1981259575 hasConceptScore W1981259575C121332964 @default.
- W1981259575 hasConceptScore W1981259575C121608353 @default.
- W1981259575 hasConceptScore W1981259575C126322002 @default.
- W1981259575 hasConceptScore W1981259575C141071460 @default.
- W1981259575 hasConceptScore W1981259575C168563851 @default.
- W1981259575 hasConceptScore W1981259575C188816634 @default.
- W1981259575 hasConceptScore W1981259575C204243189 @default.
- W1981259575 hasConceptScore W1981259575C2780011451 @default.
- W1981259575 hasConceptScore W1981259575C2780842393 @default.
- W1981259575 hasConceptScore W1981259575C2780868729 @default.
- W1981259575 hasConceptScore W1981259575C2991741193 @default.
- W1981259575 hasConceptScore W1981259575C61511704 @default.
- W1981259575 hasConceptScore W1981259575C71924100 @default.
- W1981259575 hasIssue "8" @default.
- W1981259575 hasLocation W19812595751 @default.
- W1981259575 hasLocation W19812595752 @default.
- W1981259575 hasOpenAccess W1981259575 @default.
- W1981259575 hasPrimaryLocation W19812595751 @default.
- W1981259575 hasRelatedWork W1967170642 @default.
- W1981259575 hasRelatedWork W2040803783 @default.